In Brief Jack Evjy, Chang Oh Turkmani, Elizabeth Fago appointed to NCAB December 11, 2020Vol.46 No.46
Cancer and industry groups file legal challenges to administration’s MFN rule December 11, 2020Vol.46 No.46By Paul Goldberg
BSA endorses Frederick Lab’s affiliation with NCI as recompetition of $500M 10-year contract nears December 11, 2020Vol.46 No.46By Alexandria Carolan and Matthew Bin Han Ong
Conversation with The Cancer Letter Patrick Hwu on the challenge of making Moffitt the “cell therapy capital of the universe” December 11, 2020Vol.46 No.46By Matthew Bin Han Ong
Drugs & Targets Danyelza receives FDA approval for treatment of neuroblastoma December 04, 2020Vol.46 No.45
Drugs & Targets Gavreto receives FDA approval for RET-altered thyroid cancers December 04, 2020Vol.46 No.45
Drugs & Targets FDA approves first PSMA-targeted PET imaging drug for in prostate cancer December 04, 2020Vol.46 No.45
Drugs & Targets European Commission approves Opdivo as second-line treatment for unresectable advanced, recurrent or metastatic ESCC December 04, 2020Vol.46 No.45
